1.09

21.10% 0.1899

Inovio Pharmaceuticals Inc (INO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$0.9001

Offen:

$0.9295

24-Stunden-Volumen:

12.13M

Relative Volume:

4.03

Marktkapitalisierung:

$112.63M

Einnahmen:

$65,300

Nettoeinkommen (Verlust:

$-84.93M

KGV:

-0.6382

EPS:

-1.708

Netto-Cashflow:

$-83.57M

1W Leistung:

+63.17%

1M Leistung:

-6.03%

6M Leistung:

-32.30%

1J Leistung:

-32.72%

1-Tages-Spanne:

$0.8978

$1.10

1-Wochen-Bereich:

$0.6596

$1.10

52-Wochen-Spanne:

$0.5632

$2.9789

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Firmenname

Inovio Pharmaceuticals Inc

Sektor

Healthcare (1080)

Branche

Biotechnology (604)

Telefon

(858) 410-3134

Adresse

660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Mitarbeiter

112

Twitter

@inoviopharma

Nächster Verdiensttermin

2026-08-12

Neueste SEC-Einreichungen

INO's Discussions on Twitter

Compare INO vs VRTX, REGN, ARGX, RVMD, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INO Inovio Pharmaceuticals Inc	1.09	79.56M	65,300	-84.93M	-83.57M	-1.708
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-09	Eingeleitet	Piper Sandler	Overweight
2024-05-14	Eingeleitet	Stephens	Overweight
2024-01-25	Hochstufung	Oppenheimer	Perform → Outperform
2022-11-09	Herabstufung	Maxim Group	Buy → Hold
2022-11-01	Herabstufung	BofA Securities	Neutral → Underperform
2022-07-19	Fortgesetzt	RBC Capital Mkts	Sector Perform
2022-05-11	Herabstufung	Oppenheimer	Outperform → Perform
2022-01-21	Hochstufung	BofA Securities	Underperform → Neutral
2021-12-29	Fortgesetzt	Jefferies	Hold
2021-09-10	Herabstufung	BofA Securities	Neutral → Underperform
2021-06-24	Eingeleitet	Jefferies	Hold
2021-03-23	Eingeleitet	BofA Securities	Neutral
2021-02-12	Eingeleitet	Oppenheimer	Outperform
2020-11-17	Herabstufung	ROTH Capital	Neutral → Sell
2020-11-10	Hochstufung	ROTH Capital	Sell → Neutral
2020-09-28	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2020-09-28	Hochstufung	Maxim Group	Hold → Buy
2020-07-01	Herabstufung	Maxim Group	Buy → Hold
2020-07-01	Herabstufung	ROTH Capital	Neutral → Sell
2020-06-29	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-06-26	Herabstufung	Stifel	Buy → Hold
2020-05-21	Eingeleitet	The Benchmark Company	Buy
2020-04-30	Herabstufung	ROTH Capital	Buy → Neutral
2020-03-13	Herabstufung	Piper Sandler	Overweight → Neutral
2020-03-13	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2019-12-19	Eingeleitet	ROTH Capital	Buy
2018-02-15	Bestätigt	Maxim Group	Buy
2017-10-18	Eingeleitet	RBC Capital Mkts	Outperform
2017-09-06	Eingeleitet	Citigroup	Buy
2017-06-08	Hochstufung	Piper Jaffray	Neutral → Overweight
2017-05-24	Bestätigt	Maxim Group	Buy
2017-03-16	Hochstufung	Maxim Group	Hold → Buy
2017-03-16	Herabstufung	Piper Jaffray	Overweight → Neutral

Alle ansehen

Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten

01:48 AM

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" at Wall Street Zen - MarketBeat

01:48 AM

Aug 14, 2026

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 14, 2026

HC Wainwright Issues Negative Estimate for INO Earnings - MarketBeat

Aug 14, 2026

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Strong-Buy at Zacks Research - MarketBeat

Aug 14, 2026

Aug 13, 2026

INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits

Aug 13, 2026

INO Upgraded by Jefferies -- Price Target Raised to $3.00 - GuruFocus

Aug 13, 2026

Piper Sandler Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Maintains Target Price $4 - moomoo.com

Aug 13, 2026

H.C. Wainwright reiterates Neutral on Inovio stock, $2.50 target - Investing.com

Aug 13, 2026

H.C. Wainwright reiterates Neutral on Inovio stock, $2.50 target By Investing.com - Investing.com Canada

Aug 13, 2026

Jefferies upgrades Inovio stock rating on FDA review progress - Investing.com

Aug 13, 2026

Inovio Q2 2026 slides: INO-3107 on track for Oct FDA decision - Investing.com Nigeria

Aug 13, 2026

Jefferies upgrades Inovio stock rating on FDA review progress By Investing.com - Investing.com Canada

Aug 13, 2026

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Aug 13, 2026

Inovio Pharmaceuticals (NASDAQ:INO): What Does the Latest Update Mean for Regulatory Progress? - Kalkine Media

Aug 13, 2026